Bone Biologics Corp (BBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,530 | 5,334 | 6,049 | 6,641 | 2,747 |
| Receivables | 8 | 10 | N/A | N/A | N/A |
| Other current assets | 209 | 209 | 220 | 209 | 209 |
| TOTAL | $4,979 | $5,796 | $6,351 | $7,002 | $3,162 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $4,979 | $5,796 | $6,351 | $7,002 | $3,162 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 309 | 418 | 333 | 404 | 248 |
| Other current liabilities | 0 | 1 | 1 | 2 | 3 |
| TOTAL | $309 | $419 | $334 | $406 | $251 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $309 | $419 | $334 | $406 | $251 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,795 | 1,795 | 1,795 | 1,795 | 545 |
| Common Shares | 2 | 2 | 2 | 2 | 3 |
| Retained earnings | -88,896 | -88,130 | -87,446 | -86,779 | -86,039 |
| TOTAL | $4,670 | $5,378 | $6,017 | $6,596 | $2,911 |
| Total Liabilities And Equity | $4,979 | $5,796 | $6,351 | $7,002 | $3,162 |